Skip to main content

Table 2 Comparison between group I (control group) and group II (case group) regarding complications occurred during the course of treatment

From: Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

 

Group I

Group II

Test valuea

p value

No.

%

No.

%

Patient stopped treatment

0

0.0

6

12.0

6.383

0.012

Death

0

0.0

3

6.0

3.093

0.079

Blood transfusion

0

0.0

5

10.0

5.263

0.022

Itching

0

0.0

2

4.0

2.041

0.153

Sever fatigue

0

0.0

3

6.0

3.093

0.079

Gastrointestinal symptoms

0

0.0

7

14.0

7.527

0.006

  1. aChi-square test